These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30411639)

  • 1. In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1.
    Tumdam R; Kumar A; Subbarao N; Balaji BS
    SAR QSAR Environ Res; 2018 Dec; 29(12):975-996. PubMed ID: 30411639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach.
    Shanmugam V; Muthukrishnan S
    J Biomol Struct Dyn; 2023; 41(23):14524-14539. PubMed ID: 36841551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural variation of protein-ligand complexes of the first bromodomain of BRD4.
    Guest EE; Pickett SD; Hirst JD
    Org Biomol Chem; 2021 Jun; 19(25):5632-5641. PubMed ID: 34105560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potent BRD4-BD1 inhibitors using classical and steered molecular dynamics based free energy analysis.
    Gupta A; Purohit R
    J Cell Biochem; 2024 Mar; 125(3):e30532. PubMed ID: 38317535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
    Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
    J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel BRD4-BD2 inhibitors via in silico approaches: QSAR techniques, molecular docking, and molecular dynamics simulations.
    Tong JB; Xiao XC; Luo D; Xu HY; Xing YC; Gao P; Liu Y
    Mol Divers; 2024 Apr; 28(2):671-692. PubMed ID: 36773087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel natural product inhibitors of BRD4 using high throughput virtual screening and MD simulation.
    Barman S; Sahoo SS; Padhan J; Sudhamalla B
    J Biomol Struct Dyn; 2023 Dec; 41(20):10569-10581. PubMed ID: 36524430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning.
    Wang J; Yang W; Zhao L; Wei B; Chen J
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site.
    Liu Z; Li Y; Chen H; Lai HT; Wang P; Wu SY; Wold EA; Leonard PG; Joseph S; Hu H; Chiang CM; Brasier AR; Tian B; Zhou J
    J Med Chem; 2022 Feb; 65(3):2388-2408. PubMed ID: 34982556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors.
    Qiao XP; Wang XT; Wang S; Mu HX; Wang QS; Chen SW
    Bioorg Med Chem; 2024 May; 106():117752. PubMed ID: 38749341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 envelope protein attain K
    Agrahari AK; Srivastava M; Singh M; Asthana S
    J Biomol Struct Dyn; 2023; 41(24):15305-15319. PubMed ID: 36907648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel bromodomain-containing protein 4 (BRD4-BD1) inhibitors combined with 3d-QSAR, molecular docking and molecular dynamics in silico.
    Liu R; Chen X; Li J; Liu X; Shu M
    J Biomol Struct Dyn; 2024 Feb; ():1-18. PubMed ID: 38425011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosporone E analogues as BRD4 inhibitors for cancer treatment: molecular docking and molecular dynamic investigations.
    Makki AA; Ibraheem W; Alzain AA
    J Biomol Struct Dyn; 2023; 41(22):12643-12653. PubMed ID: 36644887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.
    Ayoub AM; Hawk LML; Herzig RJ; Jiang J; Wisniewski AJ; Gee CT; Zhao P; Zhu JY; Berndt N; Offei-Addo NK; Scott TG; Qi J; Bradner JE; Ward TR; Schönbrunn E; Georg GI; Pomerantz WCK
    J Med Chem; 2017 Jun; 60(12):4805-4817. PubMed ID: 28535045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding selectivity of inhibitors toward the first over the second bromodomain of BRD4: theoretical insights from free energy calculations and multiple short molecular dynamics simulations.
    Wang Y; Wu S; Wang L; Yang Z; Zhao J; Zhang L
    RSC Adv; 2020 Dec; 11(2):745-759. PubMed ID: 35423696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability.
    Jennings LE; Schiedel M; Hewings DS; Picaud S; Laurin CMC; Bruno PA; Bluck JP; Scorah AR; See L; Reynolds JK; Moroglu M; Mistry IN; Hicks A; Guzanov P; Clayton J; Evans CNG; Stazi G; Biggin PC; Mapp AK; Hammond EM; Humphreys PG; Filippakopoulos P; Conway SJ
    Bioorg Med Chem; 2018 Jul; 26(11):2937-2957. PubMed ID: 29776834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of BET bromodomains.
    Filippakopoulos P; Qi J; Picaud S; Shen Y; Smith WB; Fedorov O; Morse EM; Keates T; Hickman TT; Felletar I; Philpott M; Munro S; McKeown MR; Wang Y; Christie AL; West N; Cameron MJ; Schwartz B; Heightman TD; La Thangue N; French CA; Wiest O; Kung AL; Knapp S; Bradner JE
    Nature; 2010 Dec; 468(7327):1067-73. PubMed ID: 20871596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a potent orally available pyrazolopyridone derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor.
    Hagihara S; Ishizawa K; Soga K; Honjo T; Takai S; Kawano Y; Kikuchi M; Nishidate A; Matsumoto F; Murase M; Hashimoto N; Sasaki C; Miyaguchi I; Okada O; Akashi T; Nakayama S; Ogasawara Y; Endo J
    Bioorg Med Chem Lett; 2024 Sep; 109():129849. PubMed ID: 38876177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands.
    Hewings DS; Fedorov O; Filippakopoulos P; Martin S; Picaud S; Tumber A; Wells C; Olcina MM; Freeman K; Gill A; Ritchie AJ; Sheppard DW; Russell AJ; Hammond EM; Knapp S; Brennan PE; Conway SJ
    J Med Chem; 2013 Apr; 56(8):3217-27. PubMed ID: 23517011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fast, open source implementation of adaptive biasing potentials uncovers a ligand design strategy for the chromatin regulator BRD4.
    Dickson BM; de Waal PW; Ramjan ZH; Xu HE; Rothbart SB
    J Chem Phys; 2016 Oct; 145(15):154113. PubMed ID: 27782467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.